BDBM63216 (4,5-diphenyl-1,2,4-triazol-3-yl) N-(4-chloroanilino)-2-oxopropanimidothioate::(4,5-diphenyl-1,2,4-triazol-3-yl) N-[(4-chlorophenyl)amino]-2-oxidanylidene-propanimidothioate::MLS000588821::N-(4-chloroanilino)-2-keto-thiopropionimidic acid (4,5-diphenyl-1,2,4-triazol-3-yl) ester::N-(4-chloroanilino)-2-oxopropanimidothioic acid (4,5-diphenyl-1,2,4-triazol-3-yl) ester::SMR000212372::cid_1599521

SMILES Cc1cccc(-c2nn(CC(=O)Nc3cc(F)cc(C(=O)OCCN4CC4)c3)cc2-c2ccnc3ccccc23)n1

InChI Key InChIKey=LIWPNFVMJZMRDJ-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 63216   

TargetTGF-beta receptor type-1(Human)
Agomab Spain S.L.U.

US Patent
LigandChemical structure of BindingDB Monomer ID 63216BDBM63216(2-(aziridin-1-yl)ethyl 3-fluoro-5-(2-(3-(6-methylp...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent